Screener
Bunge BG Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 4.9%-1.3pp | 4.4%-1.6pp | 4.8%-1.5pp | 5.8%-0.8pp | 6.3%-0.6pp | |
| Net margin | 1.1%-1.6pp | 0.8%-1.3pp | 1.2%-1.0pp | 2.2%+0.1pp | 2.7%+0.4pp | |
| Returns | ||||||
| Return on equity | 7.5%-5.7pp | 5.1%-5.2pp | 6.3%-4.6pp | 10.2%-0.6pp | 13.2%+1.0pp | |
| Return on invested capital | 5.9%-4.2pp | 5%-4.8pp | 5.3%-5.2pp | 7%— | 10.1%— | |
| Efficiency | ||||||
| Asset turnover | 2.4×+0.5× | 2.2×+0.2× | 2×-0.1× | 1.7×-0.5× | 1.8×-0.4× | |
| Liquidity | ||||||
| Current ratio | 1.6×-0.5× | 1.6×-0.4× | 1.6×-0.5× | 1.7×-0.4× | 2.1×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 1.3×-0.1× | 1.2×+0.4× | 1.2×+0.4× | 1.4×+0.6× | 1.4×+0.8× | |
| Net debt / EBITDA | 6.7×+3.4× | 7.6×+5.2× | 7.5×+5.6× | 7×+5.1× | 3.2×+1.2× | |
| Per Share | ||||||
| Book value per share | $81.67+1.8% | $81.97+4.9% | —— | $79.45+11.4% | $80.26+14.9% | |
| Valuation | ||||||
| Market capitalization | $20.25B+25.6% | $24.61B+140% | $17.22B+58.6% | $16.26B+18.7% | $11.23B-25.7% | |
| Price / earnings | 20.1×+8.4× | 36×+26.7× | 21.1×+11.6× | 12.3×+0.4× | 8.2×-3.4× | |
| Price / sales | 0.2×-0.1× | 0.3×+0.1× | 0.2×0.0× | 0.3×0.0× | 0.2×0.0× | |
| Price / book | 1.3×-0.2× | 1.5×+0.6× | 1.1×0.0× | 1×-0.3× | 1×-0.5× | |
| EV / EBITDA | 13.2×+4.1× | 17.7×+11.0× | 14.5×+8.2× | 12.6×+5.6× | 7.3×0.0× | |
| Dividend yield | 2.7%+0.4pp | 2%-1.6pp | 2.7%-0.8pp | 2.6%-0.2pp | 3.3%+0.8pp |
FAQ
- Where do Bunge's ratios come from?
- Every ratio is computed from Bunge's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
